Published in Vaccine Weekly, February 12th, 2003
"All animals developed high levels of VN antibody and MV-specific IFN-gamma-producing cells," reported Koert J. Stittelaar and colleagues at the Institute of Virology at Erasmus MC in Rotterdam and the National Institute of Public Health and the Environment in Bilthoven. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2003-02-12)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.